NASDAQ:RKDA Arcadia Biosciences Q1 2026 Earnings Results & Report $0.26 -0.01 (-3.40%) As of 04:00 PM Eastern Arcadia Biosciences missed analyst expectations on both earnings and revenue in its Q1 2026 results, released May 14, 2026. The company reported EPS of -$2.11 versus the -$0.80 consensus estimate, while revenue of $1.10 million fell short of the $1.60 million estimate by $0.50 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2026Report DateMay 14, 2026TimeBefore Market OpensConference Call4:00 PM ET Arcadia Biosciences EPS ResultsActual EPS-$2.11Consensus EPS -$0.80Beat/MissMissed by -$1.31One Year Ago EPSN/AEPS Beat Rate4 of last 8 quartersArcadia Biosciences Revenue ResultsActual Revenue$1.10 millionExpected Revenue$1.60 millionBeat/MissMissed by -$500.00 thousandYoY Revenue GrowthN/AUpcoming EarningsArcadia Biosciences' Q3 2026 earnings is estimated for Thursday, November 5, 2026, based on past reporting schedulesConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Arcadia Biosciences Q1 2026 Earnings FAQ Did Arcadia Biosciences beat earnings estimates for Q1 2026? Arcadia Biosciences (NASDAQ:RKDA) reported earnings of -$2.11 per share for Q1 2026, missing the consensus estimate of -$0.80. The report was announced on Thursday, May 14, 2026. What was Arcadia Biosciences' revenue for Q1 2026? Arcadia Biosciences reported revenue of $1.10 million for Q1 2026, against a consensus estimate of $1.60 million. When is Arcadia Biosciences' next earnings date? Arcadia Biosciences' next earnings date is estimated for Thursday, November 5, 2026. MarketBeat tracks confirmed and estimated earnings dates for Arcadia Biosciences on the company's earnings history page. Arcadia Biosciences Earnings HeadlinesArcadia Biosciences (NASDAQ:RKDA) Shares Cross Below 50-Day Moving Average - Here's What HappenedOctober 7 at 3:21 AM | americanbankingnews.comFinancial Contrast: Arcadia Biosciences (NASDAQ:RKDA) & Constellation Brands (NYSE:STZ)October 4, 2026 | americanbankingnews.comDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.October 9 at 1:00 AM | Stansberry Research (Ad)Arcadia Biosciences, Inc. (NASDAQ:RKDA) Stock Short Interest Declines 48.8%September 29, 2026 | americanbankingnews.comArcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business HighlightsAugust 13, 2026 | globenewswire.comRKDA Share News TodayJuly 6, 2026 | uk.investing.comSee More Arcadia Biosciences Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Arcadia Biosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arcadia Biosciences and other key companies, straight to your email. Email Address About Arcadia BiosciencesArcadia Biosciences (NASDAQ:RKDA) is an agricultural biotechnology company focused on developing and commercializing plant-based products and crop technologies designed to address health, nutrition and sustainability needs. The company has worked to improve the nutritional profile and agricultural performance of crops through biotechnology and plant-breeding programs. Arcadia’s product portfolio has included GoodWheat, a line of wheat varieties and wheat-based foods developed to contain reduced levels of gluten and other targeted nutritional characteristics. The company has also pursued hemp-related products and other consumer health and wellness offerings, while historically developing crop traits intended to improve characteristics such as nitrogen-use efficiency, salinity tolerance and yield. Founded in 2002, Arcadia Biosciences has been based in Davis, California, and has served agricultural, food and consumer markets through research, product development, licensing and commercialization activities. Its business focus and product portfolio have evolved over time as the company has emphasized commercial opportunities in plant-based nutrition and wellness.View Arcadia Biosciences ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep ValueMicrosoft Is Almost Back to $555—Now the Hard Part BeginsSkydance Just Became a Media Giant—With an $80 Billion Debt Load Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
